TABLE 1.
Demographic characteristics of women in the CDC’s NBCCEDP cohort, 2009 to 2017
| n | % | |
|---|---|---|
| Total | 363,546 | ~ |
| Age, y | ||
| 30–39 | 52,746 | 14.5 |
| 40–49 | 146,340 | 40.3 |
| 50–59 | 129,224 | 35.6 |
| 60–64 | 35,236 | 9.7 |
| Race and ethnicity | ||
| Non-Hispanic White | 125,990 | 34.7 |
| Non-Hispanic Black | 47,482 | 13.1 |
| Hispanic | 146,073 | 40.2 |
| Asian or Pacific Islander | 20,788 | 5.7 |
| American Indian/Alaskan Native | 16,432 | 4.5 |
| Multiracial | 2407 | 0.7 |
| Unknown | 4374 | 1.2 |
| Screening status | ||
| Screened within 5 y | 208,658 | 57.4 |
| Never or rarely screened | 113,126 | 31.1 |
| Unknown screening history | 41,762 | 11.5 |
| HPV result | ||
| Positive | 48,979 | 13.5 |
| Negative | 314,567 | 86.5 |
| Cytology by HPV result | ||
| NILM | 292,296 | 80.4 |
| HPV negative | 271,862 | 93 |
| HPV positive | 20,434 | 7 |
| ASC-US | 57,356 | 15.8 |
| HPV negative | 38,382 | 66.9 |
| HPV positive | 18,974 | 33.1 |
| LSIL | 8883 | 2.4 |
| HPV negative | 2455 | 27.6 |
| HPV positive | 6428 | 72.4 |
| ASC-H | 1479 | 0.4 |
| HPV negative | 496 | 33.5 |
| HPV positive | 983 | 66.5 |
| HSIL+ | 1863 | 0.5 |
| HPV negative | 198 | 10.6 |
| HPV positive | 1665 | 89.4 |
| AGC | 1667 | 0.5 |
| HPV negative | 1172 | 70.3 |
| HPV positive | 495 | 29.7 |
| Unsatisfactory | 2 | 0 |
| HPV negative | 2 | 100 |
| HPV positive | 0 | 0 |
AGC, atypical glandular cell; ASC-H, atypical squamous cells; ASC-US, atypical squamous cells of uncertain significance; CDC, Centers for Disease Control and Prevention; HPV, human papillomavirus; HSIL, high-grade squamous intraepithelial lesion; cannot exclude HSIL; LSIL, low-grade squamous intraepithelial lesion; NBCCEDP, National Breast and Cervical Cancer Early Detection Program; NILM, negative for intraepithelial lesion or malignancy.